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9RESEARCH Open AccessCardiopulmonary exercise testing early after stroke
using feedback-controlled robotics-assisted treadmill
exercise: test-retest reliability and repeatability
Oliver Stoller1,2,3*, Eling D de Bruin2,4,5, Matthias Schindelholz1,3, Corina Schuster-Amft1,3, Rob A de Bie2,5
and Kenneth J Hunt1,3Abstract
Background: Exercise capacity is seriously reduced after stroke. While cardiopulmonary assessment and intervention
strategies have been validated for the mildly and moderately impaired populations post-stroke, there is a lack of
effective concepts for stroke survivors suffering from severe motor limitations. This study investigated the test-retest
reliability and repeatability of cardiopulmonary exercise testing (CPET) using feedback-controlled robotics-assisted
treadmill exercise (FC-RATE) in severely motor impaired individuals early after stroke.
Methods: 20 subjects (age 44–84 years, <6 month post-stroke) with severe motor limitations (Functional Ambulatory
Classification 0–2) were selected for consecutive constant load testing (CLT) and incremental exercise testing (IET)
within a powered exoskeleton, synchronised with a treadmill and a body weight support system. A manual
human-in-the-loop feedback system was used to guide individual work rate levels. Outcome variables focussed on
standard cardiopulmonary performance parameters. Relative and absolute test-retest reliability were assessed by
intraclass correlation coefficients (ICC), standard error of the measurement (SEM), and minimal detectable change
(MDC). Mean difference, limits of agreement, and coefficient of variation (CoV) were estimated to assess repeatability.
Results: Peak performance parameters during IET yielded good to excellent relative reliability: absolute peak
oxygen uptake (ICC =0.82), relative peak oxygen uptake (ICC =0.72), peak work rate (ICC =0.91), peak heart rate
(ICC =0.80), absolute gas exchange threshold (ICC =0.91), relative gas exchange threshold (ICC =0.88), oxygen cost
of work (ICC =0.87), oxygen pulse at peak oxygen uptake (ICC =0.92), ventilation rate versus carbon dioxide
output slope (ICC =0.78). For these variables, SEM was 4-13%, MDC 12-36%, and CoV 0.10-0.36. CLT revealed high
mean differences and insufficient test-retest reliability for all variables studied.
Conclusions: This study presents first evidence on reliability and repeatability for CPET in severely motor impaired
individuals early after stroke using a feedback-controlled robotics-assisted treadmill. The results demonstrate good to
excellent test-retest reliability and appropriate repeatability for the most important peak cardiopulmonary performance
parameters. These findings have important implications for the design and implementation of cardiovascular exercise
interventions in severely impaired populations. Future research needs to develop advanced control strategies to enable
the true limit of functional exercise capacity to be reached and to further assess test-retest reliability and repeatability
in larger samples.
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Exercise capacity and activity status have become well-
established predictors of cardiovascular and overall mortal-
ity, both of which are seriously reduced after stroke [1,2]. It
has been shown that peak oxygen uptake (VO2peak) is ap-
proximately 50% lower compared to normative values of
healthy adults 30 days post-stroke [3,4]. Despite extensive
inpatient rehabilitation procedures and spontaneous recov-
ery of cardiovascular fitness, the exercise capacity of stroke
survivors entering the chronic phase remains below rec-
ommended levels [5]. The rapid deterioration of fitness not
only predisposes to secondary medical complications, but
also restricts the degree to which individuals can partici-
pate in rehabilitation routines and limits the ability of the
individual to perform functional activities independently
[6]. Therefore, research into cardiovascular exercise train-
ing in the early stages after stroke has been highlighted as a
priority [7,8]. Effective assessment and intervention strat-
egies are needed to assess, monitor, and improve cardio-
vascular fitness early after stroke.
Current research has investigated several modalities
for cardiopulmonary exercise testing (CPET) in subacute
stroke (6 days-6 months post-stroke) [3,4,9-13] and in
chronic stroke (>6 months post-stroke) [14-19] using
treadmill exercise [14-16], body weight supported tread-
mill exercise [3], leg cycle ergometry [4,9-11,15,17,18],
and combined upper- and lower-limb ergometry [12,19].
The most common concepts, i.e. treadmill exercise and
leg cycle ergometry, are primarily designed for individ-
uals with mild to moderate motor impairment, because
limited motor control (non-ambulatory status, limited
trunk control), poor postural control, and poor coordin-
ation of the affected limbs may restrict severely impaired
individuals from performing on these devices. As a result,
most studies focussing on exercise capacity after stroke
have excluded individuals not able to walk independently
and those presenting with low levels of motor function.
A potential option to overcome severe motor restric-
tions is the introduction of combined upper- and lower-
limb ergometry [12,19,20]. Current study results demon-
strated feasibility and validity, and emphasised the fact
that an all-extremity exercise protocol might decrease
early onset of lower limb fatigue which leads to better
estimates of exercise capacity due to the incorporation
of more muscle mass. However, this approach does not
embody the concept of repetitive task-specific exercise
during the early stages of stroke recovery and might be
not appropriate for implementation into early rehabilita-
tion phases [21,22]. Considering the relatively short
intervention window during subacute stroke rehabilita-
tion and the current recommendations for cardiovascu-
lar exercise training after stroke [8], novel approaches
should incorporate task-specific activities such as walking
or stair climbing. The combination of motor functiontraining and cardiovascular exercise might have the poten-
tial to positively influence overall therapy outcomes and to
prevent or mitigate the loss of exercise capacity in the
early stages after stroke onset [23].
A promising approach to overcome motor limitations
while facilitating task-specific activity and cardiovascular
stress is body weight supported treadmill training. Initial
research has shown that gait symmetry improved with
increasing body weight support (BWS) [24]. However,
during walking with BWS of more than 15%, vertical
ground reaction forces and functional activity of anti-
gravity muscles decreased, which led to substantially lower
oxygen uptake levels during body weight supported tread-
mill training compared to conventional treadmill exercise
[25,26]. Because severely impaired stroke survivors need
considerable physical support during walking with low
body weight support, the application of robotics-assisted
treadmill exercise (RATE) might be of relevance in this
context. A powered exoskeleton for the lower extremities,
synchronised with a treadmill and BWS, provides active
support during the gait trajectory that enables progressive
body weight loading for individuals with severe motor
restrictions.
Recent research on exercise intensity during RATE has
shown substantial increases in cardiopulmonary perform-
ance parameters after stroke [27,28], and spinal cord in-
jury [29], including complete tetraplegia [30]. However,
oxygen uptake levels were below that of overground walk-
ing, recommended cardiovascular training intensities
could not be achieved [31], and conventional control strat-
egies such as the modulation of walking speed, BWS, and
guidance force had only a minor influence on exercise in-
tensity [27,28,31]. There is a need for voluntary effort dur-
ing walking within an exoskeleton to provoke substantial
cardiovascular stress comparable to conventional tread-
mill exercise [32]. Therefore, novel protocols have been
developed to control and direct active participation during
RATE with the specific aim of provoking cardiorespiratory
responses [33-38]. This incorporates biofeedback mecha-
nisms allowing the control of exercise intensity through
the guidance of the individual’s voluntary effort. The ap-
proach presented here provides control of exercise in-
tensity during RATE by biofeedback and voluntary
adaptation of the hip and knee forces by the subject. A
first clinical study in non-ambulatory stroke survivors
in the subacute phase revealed that feedback-controlled
RATE (FC-RATE) can be used to implement CPET
[39]. Results yielded acceptable cardiopulmonary per-
formance parameters following standardized CPET pro-
tocols. Thus, this approach might have the potential to
assess exercise capacity and guide cardiovascular exer-
cise in stroke survivors with severe motor limitations.
This needs to be formally investigated for clinical feasi-
bility, test-retest reliability and repeatability.
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feasibility of FC-RATE for CPET in severely motor im-
paired individuals early after stroke, (2) to examine the
ability of the concept to meet standard cardiopulmonary
criteria for maximal exercise capacity, and (3) to assess the
test-retest reliability and the repeatability of the approach.
Methods
Participants
20 first-ever stroke inpatients were recruited at a
neurological rehabilitation clinic in the north-western
part of Switzerland (Reha Rheinfelden) and screened
according to the selection criteria. Subjects were then
presented to the responsible ward physician and a
cardiologist to confirm eligibility. Inclusion criteria
were: (1) clinical diagnosis of initial stroke (ischemic
or haemorrhagic), (2) <20 weeks after stroke onset,
(3) age >18 years, (4) Functional Ambulation Classification
(FAC) of <3, (5) ability to understand the procedures
and provide informed consent. Subjects were excluded
if they had (1) cardiac contraindications for exercise
testing according to the American College of Sports
Medicine (ACSM) [40], (2) contraindications for RATE ac-
cording to guidelines from the manufacturer (Hocoma
AG, Volketswil, Switzerland), (3) concurrent neurological
disease (e.g. Multiple Sclerosis, Parkinson’s Disease, etc.),
(4) concurrent pulmonary disease (e.g. COPD, etc.), (5) his-
tory of dementia.
Recorded characteristics included gender, age, body
mass index, diagnosis, affected body side, time post-
stroke, medications, comorbidities, FAC [41] and func-
tional independence using the Extended Barthel Index
[42]. All subjects were informed about risks and benefits,
and gave signed informed consent. The Ethics Review
Committee of the Swiss canton of Aargau approved the
study (Reference No: 2012/051).
Technical implementation
The Lokomat system (Hocoma AG, Volketswil, Switzerland)
was used to implement FC-RATE. The powered exo-
skeleton provides control of both legs using DC mo-
tors, synchronised with an integrated treadmill (h/p/
cosmos sports & medical GmbH, Traunstein, Germany)
and a motor-driven BWS system with real time feed-
back control for precise body weight unloading (Lokolift,
Hocoma AG). The total mechanical work rate exerted on
the exoskeleton by the subject was computed from the
force, moment arm and velocity data at the four active
joints (hips and knees). The active mechanical work rate
(Pmech), applied by the subject’s effort was estimated by
subtracting the passive mechanical work rate (work rate
necessary to move the subject passively within the exo-
skeleton) from the total mechanical work rate. A manual
human-in-the-loop feedback system was implemented tocontrol the subject’s active work rate. Pmech was pro-
jected onto a screen at the front of the treadmill together
with a target mechanical work rate (P*mech). The subject
was instructed to vary the forces applied on the exoskel-
eton by volitional muscle activity and to keep the mea-
sured and visualized active work rate as close as possible
to the target (Figure 1).Experimental protocol
At study entry, all included subjects completed a famil-
iarisation session with the FC-RATE concept, which
started by qualified and experienced physiotherapists
adjusting the Lokomat system to provide a physiological
gait pattern and to ensure that the subjects could walk
comfortably. Then, an initial test of decreasing BWS
continuously by 5% per minute was implemented to de-
fine the minimal possible BWS level. There was strict
adherence to physiological gait pattern criteria through
visual observation: (1) heel strike (physiological knee ex-
tension), (2) no foot dragging during the swing phase,
and (3) active weight-bearing during the stance phase
(physiological knee extension) [43]. After the first adjust-
ments, subjects were asked to perform a short constant
load exercise test for 5 min (P*mech =20 W) to explain
the approach and practice with the feedback-control
structure. Finally, the safety procedures for potential ad-
verse events were explained in detail.
After a break of at least 24 h, subjects then completed
repeated constant load testing (CLT) and incremental
exercise testing (IET) on separate days, with 48–72 h be-
tween the trials. All sessions were controlled for time of
day. Subjects were instructed to avoid additional strenu-
ous activity during participation in the study and not to
consume food, alcohol, nicotine or caffeine at least 3 h
prior to testing.
Subjects were asked at the beginning of the first CLT
and IET to increase their maximal voluntary effort dur-
ing RATE within 30 s to define the maximal work rate
(Pmax) for the subsequent tests. Walking cadence was
fixed at 60 steps/min and individual BWS was consistent
for all sessions. An experienced examiner performed all
tests. There was close adherence to established models for
exercise testing according to the ACSM guidelines [40].
CLT was based on constant-intensity exercise (40%
Pmax) separated into 4 phases: (1) rest - subjects stood
on the treadmill for 5 min with 0% BWS, (2) passive
phase - subjects walked passively with their individual
BWS for 5 min, (3) active phase - subjects actively con-
tributed to the walking by pushing forward within the
exoskeleton during the swing phase of each leg to reach
the target work rate for 10 min, (4) recovery - subjects
walked passively with their individual BWS for 5 min
(Figure 2A).
Figure 1 Feedback-controlled robotics-assisted treadmill exercise. Hip and knee joint forces and angles are measured in real time to allow
calculation of the mechanical work rate (Pmech, solid line) and projection onto a screen in front of the subject. Individual target work rate
profiles (P*mech, dashed line) are used to guide exercise intensity during robotics-assisted walking. The passive mechanical work rate (Ppassive) is
evaluated before every session and subtracted from Pmech. Legend: Praw = raw mechanical work rate, Μi = moments of force, ωi = angular velocity,
Ptotal = total mechanical work rate.
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rated into 4 phases: (1) rest - subjects stood on the
treadmill for 5 min with 0% BWS, (2) passive phase -
subjects walked passively with their individual BWS for
5 min, (3) active phase - subjects actively contributed to
the walking by pushing forward within the exoskeleton
during the swing phase of each leg to reach the target
work rate, (4) recovery - subjects walked passively with
their individual BWS for 5 min. The progressive rampFigure 2 Exercise testing protocols. Schematic representation of constan
feedback-controlled robotics-assisted treadmill exercise. The dashed line re
exercise testing was estimated such that the predefined work rate maximu
individual termination criteria were met the incremental phase was ended(active phase) was defined as a continuous slope aiming
to the reach predefined Pmax in 10 min (Figure 2B).
Both test protocols followed strict termination criteria for
CPET including: (1) abnormal blood pressure responses, i.e.
hypertensive (systolic >210 mmHg/diastolic >115 mmHg)
when exercising at high work rate, or hypotensive re-
sponses (decrease of >10 mmHg) despite an increase in
work rate, (2) individual work rate below target work
rate for 60 s, (3) peak heart rate within 10 beats pert load testing, CLT, (A) and incremental exercise testing, IET, (B) using
presents the target work rate (P*mech). The slope during incremental
m (Pmax) was reached at 10 min during the active phase. When
and P*mech set back to the passive level (recovery).
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where the formula was adjusted down to 70% of heart
rate maximum for subjects on beta-blocker medications
[45], (d) pain or discomfort. Subjects rated their per-
ceived exertion using the Borg rating of perceived exer-
tion scale (RPE) (6 = no exertion at all, 20 = maximal
exertion) [46].
Several risk management strategies were implemented to
ensure subjects’ safety: (1) clearly defined eligibility criteria
to include medically stable subjects only, (2) screening by
cardiologists to exclude subjects with potential risk factors
(i.e. abnormalities in resting ECG, history of any cardiac/
cardiovascular disease, uncontrolled metabolic disease),
(3) continuous blood pressure and heart rate monitoring
during exercise testing, (4) presence of resuscitation-trained
assistants, (5) opportunity to call the emergency medical re-
suscitation team in the clinic, and (6) presence of personnel
trained to release the subject within 60 s from the exoskel-
eton. Detailed information on FC-RATE-based CPET can
be found elsewhere [39,47].
Outcomes
Measured cardiopulmonary performance parameters were:
oxygen uptake (VO2), carbon dioxide output (VCO2), ven-
tilation rate (VE), respiratory rate (Rf), and heart rate (HR).
These were recorded by a breath-by-breath cardiorespira-
tory monitoring system (MetaMax 3B, Cortex Biophysik,
Leipzig, Germany), including a heart rate belt (T31, Polar
Electro, Kempele, Finland) and a receiver board (HRMI,
Sparkfun, Boulder, USA). Pmech was calculated using the
exoskeleton geometry and interaction forces, and angular
signals, which were available in real time from a custom
interface unit.
For CLT, outcome variables were speed of oxygen uptake
kinetics (time constant τ), oxygen cost of passive walking
(Δ rest vs. passive walking), oxygen cost of active walking
(Δ passive walking vs. active walking), and accuracy of
work rate tracking (RMSEP). IET focused on peak perform-
ance parameters for oxygen uptake (VO2peak), time to
VO2peak (tVO2peak), work rate (Ppeak), ventilation rate
(VEpeak), respiratory rate (Rfpeak), heart rate (HRpeak),
and respiratory exchange ratio (RERpeak). In addition, gas
exchange threshold (GET), oxygen cost of work (ΔVO2/
ΔP), O2 pulse at VO2peak (O2pulse), VE versus VCO2 slope
(ΔVE/ΔVCO2), and RMSEP were evaluated.
Data processing
Raw breath-by-breath data were processed using a zero
phase shift moving average filter over 15 breaths [48].
For CLT, the time constant for the oxygen uptake kinet-
ics (τ) was calculated using a non-linear least-squares al-
gorithm to fit the data as described in the following
mono-exponential equation: VO2(t) = VO2(b) +ΔVO2
(1 ‐ e‐ (t ‐ Td)/τ), t > 0, with VO2(b) = oxygen uptake atbaseline, ΔVO2 = step increase in oxygen uptake, Td =
time delay of 20 s corresponding to the cardio-dynamic
phase of the response, and τ = time constant [49].
Steady-state was defined by excluding the first 2 minutes
and last minute of each phase, i.e. steady-state calcula-
tions were done using data from the 3rd – 4th minute of
a given phase. Cost of passive walking was defined as
the difference between rest and passive steady-state
values, whereas cost of active walking was estimated
from the difference between passive and active steady-
states. For IET, peak cardiopulmonary response variables
were defined as the maximal values in the final 30 s dur-
ing the incremental phase. Criteria for maximal aerobic
capacity were (1) plateau in oxygen uptake, (2) respira-
tory exchange ratio (RER) ≥1.15, and (3) peak heart rate
within 10 beats per minute of the age-predicted heart
rate maximum (adjusted for subjects on beta-blocker
medications) [40]. The identification of a plateau or re-
duction in VO2 was performed by plotting the slope and
95% confidence interval (CI) of the VO2-Pmech slope by
least-squares linear regression analysis, where the pres-
ence of data points that fell below and outside the ex-
trapolated 95% CI were taken as evidence of plateauing
or levelling-off behaviour [50]. The GET was estimated
using the v-slope method, where the anaerobic threshold
is identified as the deflection point of the VO2-VCO2
relationship [51]. The accuracy of work rate tracking
(RMSEP) was expressed by the root mean square error
between Pmech and P*mech. Data processing was per-
formed using MATLAB (Version R2010a, MathWorks,
Natick MA, USA) and LabVIEW (Version 2009, National
Instruments, Austin TX, USA).Statistical analysis
Descriptive statistics were calculated for all outcome
variables. Due to the small sample size, Wilcoxon-tests
were applied to exclude significant practice effects.
Test-retest reliability was quantified using intraclass
correlation coefficients (ICC3,1) with 95% CI. The ICC
provides an estimate of the relative reliability of meas-
urement when the population under study is heteroge-
neous [52]. ICC results of 0.60-0.74 were considered as
“good”, and ICC results >0.74 as “excellent” [53]. Abso-
lute reliability was determined by estimating the stand-
ard error of measurement (SEM = standard deviation of
the difference SDdiffð Þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1‐ICCp ) and the minimal detect-
able change MDC ¼ 1:96 ﬃﬃﬃ2p  SEM , presented in
absolute values and percentages [54,55]. Repeatability
was estimated by mean difference (MD), limits of
agreement (LoA) (MD ±1.96 x SDdiff ), and coefficients
of variation (CoV) (SDdiff/mean). Two-sided p-values
p ≤0.05 were considered significant. Statistical analyses
were performed using SPSS (Version 20.0, IBM, Armonk
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Natick MA, USA).
Results
General observations
Of the 20 subjects enrolled in the study, 1 subject showed
an abnormal gait pattern due to uncontrollable spasticity
during familiarisation and 1 subject developed a tibia skin
lesion due to inadequate padding of the exoskeleton,
which led to withdrawal from the study (Figure 3). Further,
4 withdrawals after the first IET occurred due to groin
pain, lack of motivation, suspected cerebrospinal fluid leak,
and acute respiratory infection. Thus, 18 subjects (90%)
performed the two CLTs and, of these, 14 (70%) also
performed the two IETs. All subjects presented with severe
motor impairments and were non-ambulatory (FAC range
0–2). BWS ranged between 46-77% and walking speed
was set at 60 steps/minute (0.47-0.67 m/s). The subject
characteristics are summarized in Table 1.
All subjects successfully completed the predefined
CPET protocol (rest, passive, active, recovery). During
CLT, 3 subjects stopped the active walking phase after
5 minutes due to generalized fatigue and continued with
the recovery phase. All other CLT conditions were per-
formed according to the plan. 13 subjects completed
both IETs without symptomatic responses requiring ter-
mination per safety criteria; the reason for test termin-
ation was in every case the inability to reach P*mech
due to generalized and/or leg fatigue. The examiner
stopped 2 consecutive IET sessions in 1 subject due to
high blood pressure responses according to the safety
criteria (2 adverse events); however, no serious adverse
events occurred during testing. Mean IET duration wasFigure 3 Study flow chart.23.2 ± 2.6 min (active phase: 8.2 ± 2.6 min). RPE at peak
performance was 14.8 ± 1.9. RMSEP values were <10 W.
Exercise capacity
For CLT, time constants of oxygen uptake kinetics (τ)
could not be evaluated due to continuous disturbances
of VO2 in the transition phases (rest/passive walking,
passive walking/active walking). Cost of passive walking
(Δ rest vs. passive walking) was (mean ± standard devi-
ation): VO2 =184.2 ± 124.0 mL/min, HR =1.4 ± 6.4
beats/min, and cost of active walking (Δ passive walk-
ing vs. active walking) was: VO2 =45.7 ± 56.6 mL/min,
HR =2.3 ± 3.1 beats/min. RMSEP during CLT was 5.5 ±
5.5 W. For IET, peak performance parameters were:
absolute VO2peak =1280.9 ± 564.8 mL/min, relative
VO2peak =15.5 ± 4.9 mL/min/kg (51.6 ± 20.5% of
predicted VO2max [56]), tVO2peak =8.2 ± 2.6 min,
Ppeak =53.9 ± 33.8 W, VEpeak =41.3 ± 18.6 L/min,
Rfpeak =36.1 ± 8.3 1/min, HRpeak =126.0 ± 19.5 beats/
min (84.3 ± 12.2% of age-predicted heart rate maximum
[44]), and RERpeak =0.92 ± 0.09. Absolute GET was at
a VO2 of 878.9 ± 316.6 mL/min and relative GET at
11.0 ± 3.1 mL/min/kg, which was GET% =72.6 ± 12.2%
of VO2peak. ΔVO2/ΔP was 20.1 ± 14.4 mL/W, O2pulse
was 10.2 ± 4.1 mL/beat, and ΔVE/ΔVCO2 was 36.3 ±
7.3 L. RMSEP during IET was 8.7 ± 9.0 W.
With respect to the 3 criteria for maximal aerobic cap-
acity, 2 subjects (14%) showed a plateau in VO2 at the
end of IET, 1 subject (7%) achieved an RER value ≥1.15,
and 5 subjects (36%) reached peak heart rate within 10
beats per minute of the age-predicted heart rate max-
imum, where 2 of these subjects had an adjusted heart
rate due to beta-blockers. Thus, 57% of the subjects
Table 1 Subject characteristics
Constant load testing Incremental exercise testing
(n =18) (n =14)
Men/women 11/7 9/5
Type of stroke: ischemic/haemorrhagic 12/6 11/3
Hemiparetic side: right/left 9/9 8/6
Time post-stroke [d] 49±31(14–139) 43±25(14–92)
Age [y] 61±11(44–84) 61±12(44–84)
BMI [kg/m2] 27±5(19–38) 28±6(19–38)
FAC (0–5) 1.1±0.8(0–2) 0.9±0.8(0–2)
EBI (0–64) 43±9(27–56) 42±9(27–55)
Medications: beta-blockers/ACE inhibitors/both 6/11/4 4/11/4
Comorbidities: Hypertension/Dyslipidemia/Adipositas/Diabetes mellitus 9/6/3/3 8/6/3/3
BWS [%] 59±9(46–77) 60±9(46–77)
Walking speed [m/s] 0.57±0.05(0.47-0.67) 0.56±0.05(0.47-0.64)
RPE (6–20) 13±2(6–17) 15±2(11–18)
Pmax [W] 38.4±23.0(8.5-77.2) 57.1±33.1(11.3-127.7)
Values are given in numbers (n) or mean ± standard deviation (range).
Abbreviations: BMI Body mass index, FAC Functional Ambulation Classification, EBI Extended Barthel Index, ACE inhibitors Angiotensin-converting enzyme inhibitors,
BWS Body weight support, RPE Rate of perceived exertion, Pmax Maximal work rate.
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Test-retest reliability and repeatability
Table 2 shows mean values, test-retest reliability and re-
peatability results of the repeated CLT and IET trials. No
practice effects could be detected; trials were not sig-
nificantly different. Outcome variables for CLT yielded
high MD between tests and insufficient test-retest reli-
ability and repeatability throughout. For IET, good to
excellent relative reliability was found for absolute
VO2peak (ICC =0.82), relative VO2peak (ICC =0.72),
Ppeak (ICC =0.91), HRpeak (ICC =0.80), absolute
GET (ICC =0.91), relative GET (ICC =0.88), ΔVO2/ΔP
(ICC =0.87), O2pulse (ICC =0.92), and ΔVE/ΔVCO2
(ICC =0.78). SEM were between 4-13% and MDC
ranged from 12-36%. MD± SDdiff of the outcome variables
that were analysed for relative reliability were: absolute
VO2peak =45.5 ± 353.7 mL/min, relative VO2peak =1.0 ±
3.8 mL/min/kg, Ppeak =2.4 ± 15.0 W, HRpeak =3.6 ±
12.6 beats/min, absolute GET =67.3 ± 124.2 mL/min,
relative GET =0.2 ± 1.6 mL/min/kg, ΔVO2/ΔP =2.7 ±
7.2 mL/min/W, O2pulse =0.1 ± 1.7 mL/beat, ΔVE/
ΔVCO2 =0.5 ± 5.1 L. CoV for peak cardiopulmonary
performance parameters ranged from 0.10-0.44. Bland–
Altman plots for the major outcome variables visualize
the differences between tests (Additional files 1, 2).
Discussion
This is the first study to evaluate the test-retest reliabil-
ity and repeatability of FC-RATE for assessment ofexercise capacity early after severe stroke. The aims
were: (1) to assess the clinical feasibility of FC-RATE
for CPET in severely motor impaired individuals early
after stroke, (2) to examine the ability of the concept to
meet standard cardiopulmonary criteria for maximal
exercise capacity, and (3) to assess the test-retest reli-
ability and the repeatability of the approach.
General observations
Despite rigorous exclusion criteria, only 90% of the sam-
ple completed both CLTs and 70% completed both IETs.
Of the 6 subjects who dropped out during the study,
only 2 were due to reasons based on uncontrollable fac-
tors such as cerebrospinal fluid leak and acute respira-
tory infection. The remaining 4 dropouts were caused by
controllable factors such as abnormal gait pattern, tibia
skin lesion, severe groin pain and lack of motivation.
Skin lesions and severe groin pain due to inappropriate
padding are preventable by extended familiarisation and
padding procedures, whereas abnormal gait patterns due
to spasticity and lack of motivation are difficult factors
to control. Advanced control strategies might provide
solutions for abnormal gait patterns and virtual reality
approaches might facilitate motivation in the near fu-
ture. Nevertheless, dropout rates were comparable with
previous CPET studies in subacute stroke [3,9-11].
The guidance of work rate for FC-RATE-based CPET
was successful. RMSEP values were below 10 W, which
can be seen as acceptable based on previous pilot study
results [39]. The approach presented here used work
rate values of both legs together and does not consider
Table 2 Test-retest reliability and repeatability of feedback-controlled robotics-assisted treadmill exercise based
cardiopulmonary exercise testing
Trial 1 Trial 2
mean±SD (range) mean±SD (range) p-value MD (LoA) CoV ICC (95% CI) SEM SEM% MDC MDC%
Constant load testing (n =18)
VO2 cost of passive walking [mL/min] 200.4±112.0 (41.4-426.4) 167.9±136.2 (−3.7-506.5) 0.23 32.5 (−182.4, 247.5) 0.58 0.62 (0.25-0.84) 66.3 36 183.7 100
VO2 cost of active walking [mL/min/W] 43.4±53.0 (−2.5-212.8) 48.1±61.4 (2.0-214.2) 0.62 4.6 (−141.2, 150.5) 1.59 0.20 (−0.31-0.61) 65.2 143 180.8 395
Heart rate cost of passive walking [beats/min] 0.6±5.9 (−14.5-7.8) 2.3±6.9 (−13.0-15.4) 0.68 1.6 (−13.2, 16.5) 5.20 0.33 (−0.15-0.68) 6.1 426 16.9 1182
Heart rate cost of active walking [beats/min/W] 2.4±3.6 (0.0-15.5) 2.1±2.5 (0.3-9.3) 0.91 0.3 (−7.1, 7.6) 1.62 0.32 (−0.18-0.68) 3.0 134 8.4 370
Deviation of work rate (RMSEP) [W] 5.4±5.3 (1.4-20.9) 5.5±5.8 (0.9-21.4) 0.95 0.0 (−11.2, 11.3) 1.03 0.50 (0.05-0.78) 4.0 73 11.0 201
Incremental exercise testing (n =14)
Peak VO2 uptake (VO2peak absolute) [mL/min] 1258.1±612.1 (460.3-2490.3) 1303.6±535.5 (583.2-2427.8) 0.47 45.5 (−662.0, 753.0) 0.28 0.82 (0.53-0.94) 150.5 12 417.1 33
Peak VO2 uptake/body mass (VO2peak relative)
[mL/min/kg]
15.0±4.8 (7.2-23.4) 15.9±5.2 (9.1-27.9) 0.33 1.0 (−6.7, 8.6) 0.25 0.72 (0.33-0.89) 2.0 13 5.6 36
Time to VO2peak (tVO2peak) [min] 7.5±1.7 (4.9-10.8) 8.8±3.2 (4.1-16.9) 0.14 1.3 (−4.2, 6.8) 0.34 0.39 (−0.09-0.74) 2.2 26 6.0 73
Peak work rate (Ppeak) [W] 52.7±33.2 (11.3-107.4) 55.1±35.6 (7.9-101.0) 0.64 2.4 (−27.7, 32.5) 0.28 0.91 (0.74-0.97) 4.5 8 12.6 23
Peak ventilation rate (VEpeak) [L/min] 40.3±18.6 (15.7-82.8) 42.4±19.3 (21.7-96.7) 0.73 2.1 (−34.5, 38.6) 0.44 0.55 (0.33-0.83) 12.3 30 34.1 82
Peak respiratory rate (Rfpeak) [1/min] 36.5±9.7 (22.7-54.7) 35.8±7.0 (23.9-44.3) 0.73 0.7 (−14.0, 15.4) 0.20 0.64 (0.18-0.87) 4.4 12 12.2 34
Peak heart rate (HRpeak) [beats/min] 124.2±17.6 (97–148) 127.9±21.8 (95–160) 0.35 3.6 (−21.6, 28.9) 0.10 0.80 (0.49-0.93) 5.7 5 15.8 13
Peak respiratory exchange ratio (RERpeak) 0.91±0.05 (0.84-1.00) 0.93±0.11 (0.79-1.21) 0.55 0.01 (−0.18, 0.21) 0.11 0.39 (−0.18-0.76) 0.08 8 0.21 23
Gas exchange threshold (GET absolute) [mL/min] 911.3±365.1 (323.8-1642.7) 844.0±265.0 (491.2-1255.1) 0.51 67.3 (−181.0, 315.6) 0.14 0.91 (0.74-0.97) 36.6 4 101.5 12
GET/body mass (GET relative) [mL/min/kg] 11.1±3.1 (5.1-14.7) 10.8±3.1 (5.3-16.6) 0.65 0.2 (−2.9, 3.4) 0.14 0.88 (0.65-0.96) 0.5 5 1.5 14
GET% of VO2peak (GET%) [%] 75.1±11.1 (59.4-94.1) 69.9±13.2 (49.8-92.4) 0.09 5.2 (−16.3, 26.8) 0.15 0.57 (0.08-0.84) 7.1 10 19.7 27
O2 cost of work (ΔVO2/ΔP) [mL/min/W] 18.7±13.8 (5.7-51.1) 21.4±15.5 (4.9-60.4) 0.12 2.7 (−11.7, 17.1) 0.36 0.87 (0.66-0.96) 2.6 13 7.1 36
O2 pulse at VO2peak (O2pulse) [mL/beat] 10.2±4.6 (3.2-19.2) 10.3±3.8 (4.4-16.2) 0.73 0.1 (−3.3, 3.4) 0.17 0.92 (0.78-0.98) 0.5 5 1.3 13
VE versus VCO2 slope (ΔVE/ΔVCO2) [L] 36.6±6.9 (20.4-47.6) 36.1±8.0 (18.4-52.2) 0.93 0.5 (−9.6, 10.6) 0.14 0.78 (0.44-0.92) 2.4 7 6.6 18
Deviation of work rate (RMSEP) [W] 8.8±10.3 (1.3-32.2) 8.5±7.7 (1.4-27.9) 0.93 0.3 (−21.9, 22.5) 1.28 0.28 (−0.32-0.70) 9.4 109 26.2 301
Abbreviations: SD Standard deviation, MD Mean difference, LoA Limits of agreement, CoV Coefficients of variation, ICC Intraclass correlation coefficient,
CI Confidence interval, SEM Standard error of the measurement, MDC Minimal detectable change.
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sult, subjects generally tend to exercise using the un-
affected side more dominantly, which led to deviations
from the predefined physiological gait pattern. The pow-
ered exoskeleton allowed the subjects to remain in an
acceptable movement trajectory during FC-RATE. While
the approach presented here aimed to recruit as much
muscle mass as possible to provoke peak exercise cap-
acity, the imbalance of muscular activation during FC-
RATE might be relevant when applying the method in
longitudinal training interventions, because continuous
imbalance in the gait cycle might facilitate unwanted
compensation patterns.
Overall, the findings present a promising method for
CPET in severely motor impaired individuals after stroke,
but important factors such as appropriate padding and
force interactions between subject and robot must be well
controlled to gain improvements towards clinical feasibility.
Exercise capacity
For CLT, the difficulty of estimating the time constants
for VO2 uptake kinetics (τ) in the transitions from rest
to passive walking and passive walking to active walking
was due to the inherent noisiness of the breath-by-
breath data and the consequent poor signal-to-noise ra-
tio. The approach presented here seems not appropriate
to provide consistent CLT outcome values for the transi-
tion phases. Sudden onset of changes in BWS and walk-
ing pattern seem to have a strong impact on individual
performance levels during conventional RATE that re-
stricts valid assessment of VO2 uptake kinetics (τ) values.
Cost of passive walking was comparable with previous
studies using an identical setup [27,31], whereas cost of
active walking was considerably higher than previous re-
sults [39]. This difference might be caused by the inclu-
sion of non-ambulatory subjects showing severe motor
impairments (FAC 2.3 vs. FAC 1.1) in the present study.
With relative VO2peak values of 15.5 ± 4.9 mL/min/kg
(51.6% of predicted VO2max), the results confirm that
exercise capacity is seriously reduced within this group
of severely motor impaired stroke survivors. Peak per-
formance parameters during IET found in this study
were slightly higher compared to previous trials using
leg cycle ergometry, body weight supported treadmill
training, and combined upper- and lower-limb ergome-
try [3,4,9-12]. This finding might be due to the introduc-
tion of treadmill exercise based CPET that has
previously confirmed higher VO2peak values compared
to leg cycle ergometry protocols [57]. Furthermore, the
feedback-control approach presented in this study might
have recruited additional muscle mass that provoked
higher peak values compared to body weight supported
treadmill training. Considering the inclusion of individuals
with serious motor impairments and the comparable peakcardiovascular performance parameters, this study opens
new perspectives regarding assessment of exercise
capacity early after severe stroke.
The GET values observed in the current study
(%GET =72.6 ± 12.2% of VO2peak) were in the upper
range compared to sedentary healthy individuals (50-76%
of VO2peak) [58], providing additional evidence of com-
promised exercise capacity in this population. ΔVO2/ΔP
was higher compared to leg cycle ergometry and conven-
tional treadmill exercise meaning that subjects required
more oxygen for a given work rate level; this may be
explained by a substantial amount of unaccounted work
performed during the test [59-61]. Further research seems
indicated to explore the impact on ΔVO2/ΔP while walk-
ing within different robotics-assisted systems.
Although the current study provides first evidence for
clinical feasibility of using FC-RATE for CPET and
promising results regarding assessment of maximal exer-
cise capacity, the issue remains of whether the concept
is able to meet traditional criteria for true maximal cap-
acity. Only 2 subjects within this study showed a plateau
in VO2 at the end of IET, traditionally considered the
primary criterion for maximal aerobic effort. This find-
ing is in line with previous studies [3,10]. Even in healthy
people, a plateau in VO2 response is not always seen
during IET [62], therefore this criterion must be recon-
sidered for future analyses. With respect to the RER,
only 1 subject achieved an RER value ≥1.15, and only 3
subjects (21%) reached RER ≥1.0. Compared to previous
studies in subacute stroke which have shown mean
RERpeak vales of 0.9 [4], 1.0 [3,10], 1.02 [13], 1.1 [9], the
results presented here are clearly in the lower range, but
not unusual in this early phase after stroke. At least 5
subjects (36%) reached peak heart rate within 10 beats
per minute of the age-predicted heart rate maximum,
which is comparable with previous findings [3,11]. Con-
sidering these results, most of the subjects appear not to
have reached their maximal aerobic capacity. The main
reason might be generalized and/or leg fatigue, because
93% of the subjects terminated the IET due to inability
to maintain the target work rate, suggesting that impair-
ments in strength, coordination, and sensorimotor con-
trol contribute to difficulties in producing high work
rate levels. These findings are consistent with previous
studies performing CPET in subacute stroke [4,10]. Ad-
vanced control strategies of powered exoskeletons, i.e.
adapting the movement trajectory to the subject’s needs
(impairment level, hemiplegic side) and synchronising
the treadmill inclination, might allow a more appropriate
challenge progression to reach higher physical perform-
ance levels in this severely impaired population, and
might provide closer approximations and comparisons
to conventional treadmill based exercise testing proce-
dures such as the Bruce or Balke protocols [59,63].
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in the submaximal range, the estimation of the work rate
slope using MWC-W was shown to be successful. The ap-
proach implemented was able to reach peak performance
within 8–12 minutes (tVO2peak =8.2 ± 2.6 min) during
IET by defining the walking cadence at 60 steps/min while
increasing the target work rate profile. This is an important
finding for further research regarding the initial estimation
of target work rate profiles for CPET in severely motor
impaired populations.
Finally, considering the peak performance results and
the low frequency of achieved criteria for VO2max of
this study, in combination with previous study results on
peak exercise capacity in subacute stroke, we hypothe-
sise that the guidelines postulated for healthy popula-
tions may not be realistic for determination of true
exercise capacity in the early stages after stroke [64-66].
Test-retest reliability and repeatability
Most studies that examined test-retest reliability using
CPET after stroke reported excellent relative reliability,
whereas only Tang et al. revealed fair to good associa-
tions between trials [10,14,15,17,18]. The present study
using a novel robotics-assisted treadmill-based method
for assessment of exercise capacity revealed good to ex-
cellent relative reliability for the major peak cardiopul-
monary performance parameters. There is only limited
evidence so far on absolute reliability for CPET early
after stroke. Compared to a previous study in chronic
stroke using leg cycle ergometry that has shown SEM
for relative VO2peak of 1 mL/min/kg (6%), our approach
presented higher SEM values (2 mL/min/kg (13%)) [15].
Likewise, a previous study that used semi-recumbent leg
cycle ergometry in subacute stroke with cognitive im-
pairments yielded considerably lower MDC values (e.g.
relative VO2peak: 0.97 mL/min/kg (4%) vs. 5.6 mL/min/kg
(36%)) compared to our study [18].
While studies in healthy subjects and individuals
with cardiac or respiratory disease have revealed high
repeatability (CoV <0.10) [64,67-69], the present study
yielded considerably higher CoV for the major cardio-
pulmonary parameters (absolute VO2peak =0.28, relative
VO2peak =0.25, Ppeak =0.28, HRpeak =0.10, absolute
GET =0.14, relative GET =0.14, ΔVO2/ΔP =0.36,
O2pulse =0.17, ΔVE/ΔVCO2 =0.14).
There was visual suspicion of heteroscedasticity for ab-
solute VO2peak and Ppeak (Additional file 1); however,
logarithmic transformation of the data (Additional file 2)
did not change the relevant outcome variables, and thus
appeared irrelevant fur further consideration. We hy-
pothesise that the increase in bias along with higher
work rate values is caused by large day-to-day variability
in strength and/or coordinative capabilities. Although
general factors that may contribute to variability in test-retest situations such as disease severity, patient instruc-
tion, time of day, testing procedure, and equipment,
were well controlled in the protocol presented here, the
novel approach might have led to additional confounding
factors that could have influenced test-retest reliability
and repeatability. A major factor was the high coordinative
demand of the concept. Subjects not only had to walk (or
pedal, as in earlier cycle ergometry studies); the challenge
was to produce additional forces in the walking direction,
where the exoskeleton restricted the movement. The re-
sults clearly indicated that the major reason for test ter-
mination was the inability to maintain P*mech, which led
to the assumption that muscular and/or coordinative
fatigue was the reason for test termination. Therefore,
variation might be reinforced by day-to-day variability
(normally ±3% [64]) and influenced by whether the test
was maximal or not. This hypothesis is supported by
the low RERpeak values reported in this study. More
sophisticated strategies are required to reduce the load
on the neuromuscular system while increasing cardio-
vascular stress during FC-RATE. This will possibly lead
to a better approximation of true exercise capacity early
after stroke and might improve the reliability and the
repeatability of FC-RATE based CPET.
The approach presented here seems suitable for com-
parison of groups of stroke individuals or for assessment
of group intervention effects in future studies, considering
the range of between-group improvement in VO2peak of
12.6-34.8% [70-73] and Ppeak of 23.4-176.9% [72-74] after
cardiovascular exercise in subacute stroke. Whether the
absolute reliability and the repeatability reported are
adequate to identify effectiveness of intervention pro-
grammes to improve exercise capacity should be part of
future studies including larger sample sizes.
Limitations
The major limitation of the current study is the small
sample size, which may render the results underpow-
ered. A sample size of at least 50 is generally seen as ad-
equate for the assessment of the agreement parameter,
based on a general guideline by Altman [75]. Consider-
ing the experimental approach of the method and the
difficulty of implementing and performing CPET in the
early stages after severe stroke, our sample of 20 subjects
at onset was a realistic group size to evaluate first esti-
mates from a clinical perspective.
The conventional sequencing of the test situations
(CLT, CLT, IET, IET) might have led to practice effects.
The severely impaired and early-post-stroke status of the
individuals included in this experimental approach may
justify this order to progressively increase the exercise
intensity over time to control potential risks.
The present study protocol did not include ECG mon-
itoring for reasons of practicability, which influenced the
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factors for CPET. While around 75% of stroke survivors
present some degree of cardiovascular disease [76], the
sample of this study might not be representative. Never-
theless, there was an uncontrolled risk for cardiac events
due to the absence of ECG despite the adherence to
strict exclusion criteria for cardiovascular disease.
While the study protocol strictly controlled time of
day for CPET, the tests were performed within 48 h or
72 h due to practical reasons. This time difference might
have affected the recovery phase of the subjects, thus in-
fluencing the results.
Conclusion
This study presents first evidence on reliability and repeat-
ability for CPET in severely motor impaired individuals
early after stroke using a feedback-controlled robotics-
assisted treadmill. The results demonstrate good to excel-
lent test-retest reliability and appropriate repeatability for
the most important peak cardiopulmonary performance
parameters. These findings have important implications
for the design and implementation of cardiovascular exer-
cise interventions in severely impaired populations. Future
research needs to develop advanced control strategies to
enable the true limit of functional exercise capacity to be
reached and to further assess test-retest reliability and re-
peatability in larger samples.
Additional files
Additional file 1: Bland-Altman plots. The difference between trial 2
(T2) and trial 1 (T1) is plotted against the mean of T1 and T2 for the
major outcome variables.
Additional file 2: Bland-Altman plots (logarithmically transformed).
The difference between trial 2 (T2) and trial 1 (T1) is plotted against the
mean of T1 and T2 for the major outcome variables.
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